Hepatitis Monthly

Published by: Kowsar

Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report

Roya Ghasemian 1 , Farhang Babamahmoodi 1 and Fatemeh Ahangarkani 1 , *
Authors Information
1 Antimicrobial Resistance Research Center, Department of Infectious Diseases, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Hepatitis Monthly: June 01, 2016, 16 (6); e38138
  • Published Online: May 25, 2016
  • Article Type: Brief Report
  • Received: April 1, 2016
  • Revised: April 24, 2016
  • Accepted: May 14, 2016
  • DOI: 10.5812/hepatmon.38138

To Cite: Ghasemian R, Babamahmoodi F, Ahangarkani F. Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report, Hepat Mon. 2016 ; 16(6):e38138. doi: 10.5812/hepatmon.38138.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Mahboobi N, Alavian SM. Hepatitis A in the Eastern Mediterranean region: a review on the prevalence. Scimetr. 2013; 2(1)
  • 2. Alavian SM. Hepatitis A. Aust Fam Physician. 2011; 40(4): 185[PubMed]
  • 3. Alavian SM. Iraq: A Hot Zone for HAV Infection? Hepat Mon. 2005; 5(3): 53-6
  • 4. Mahboobi N, Porter SR, Karayiannis P, Alavian SM. Oral fluid and hepatitis A, B and C: a literature review. J Oral Pathol Med. 2012; 41(7): 505-16[DOI][PubMed]
  • 5. Karimi Elizee P, Alavian SM, Miri SM, Behnava B, Alavian SH, Keshvari M, et al. The seroprevalence of entrically transmitted viral hepatitis in hcv infected thalassemia and hemophilia patients in iran. Jundishapur J Microbiol. 2013; 6(7)
  • 6. Salahei M, Ansari Moghaddam A, Sanei Moghaddam E, Khosravi S, Hajibeigi B, Alavian SM. The epidemiological pattern of acute viral hepatitis in Tehran and Zahedan: A comparison study. Gastroenterol Hepatol Bed Bench. 2009; 3(1)
  • 7. Ghorbani GA, Mahboobi N, Lankarani KB, Alavian SM. Hepatitis A Prevention Strategies, Haiti Case: Should Rescuers Be Immunized. Iran Red Crescent Med J. 2010; 2010(3): 221-3
  • 8. Mahboobi N, Safari S, Alavian SM. Hepatitis A virus in Middle East countries: More evidence needed. Arab J Gastroenterol. 2010; 11(1): 1-2
  • 9. Alavian SM. Hepatitis a in developed country, the result should interpret carefully. Gut Liver. 2011; 5(3): 395-6[DOI][PubMed]
  • 10. Gushulak BD, MacPherson DW. Globalization of infectious diseases: the impact of migration. Clin Infect Dis. 2004; 38(12): 1742-8[DOI][PubMed]
  • 11. Bonanni P, Boccalini S, Bechini A, Eurohep Net Team . Measurement and reporting of burden of disease for hepatitis A: results of the EUROHEP.NET feasibility survey. Eur J Public Health. 2007; 17(1): 69-74[DOI][PubMed]
  • 12. Ghorbani GA, Alavian SM, Assari S. Seroepidemiology of hepatitis A virus in Iranian soldiers in 2006: do they need vaccination. Hepat Mon. 2007; 7(1): 7-9
  • 13. Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. The Lancet. 2006; 367(9515): 1008-15
  • 14. Fiore AE, Wasley A, Bell BP. Advisory Committeee on Immunization Practices (ACIP). Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2006; 55: 1-23
  • 15. Alavian SM. Vaccination in Health Care Workers Should be Following in our Country Now?! Iran Red Crescent Med J. 2013; 15(12): 17145[DOI][PubMed]
  • 16. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2): 99-104[PubMed]
  • 17. Ramezani H, Bozorgi SH, Nooranipour M, Mostajeri A, Kargar-Fard H, Molaverdikhani S, et al. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran. Singapore Med J. 2011; 52(2): 107-12[PubMed]
  • 18. Rosenthal P. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology. 2003; 37(1): 44-51[DOI][PubMed]
  • 19. Dinelli MI, Fisberg M, Moraes-Pinto MI. Anti-hepatitis A virus frequency in adolescents at an outpatient clinic in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2006; 48(1): 43-4[PubMed]
  • 20. Alian S, Ajami A, Ghasemian R, Yadegarinia D. Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Mediterr Health J. 2011; 17(10): 754-8[PubMed]
  • 21. Salehi M, Sanei M. Hepatitis A seroepidemiology in under 30 years old population. J Guilan M Sci. 2005; 10: 37-8
  • 22. Moschen ME, Floreani A, Zamparo E, Baldo V, Majori S, Gasparini V, et al. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol. 1997; 13(8): 875-8[PubMed]
  • 23. Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, et al. Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon. 2016; 16(1): 32215[DOI][PubMed]
  • 24. Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015; 15(12): 35238[DOI][PubMed]
  • 25. Elizee PK, Alavian SM. Prevention of hepatitis a virus infection, need to vaccinate or not? Int J Prev Med. 2013; 4(8): 863-5[PubMed]
  • 26. Izadi M, Esfahani AA, Hassannia H, Jonaidi Jafari N, Rahmati Najarkolaei F, Rezaee-Zavareh MS. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench. 2016; 9(2): 100-4[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments